Dataset from A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment

The purpose of this study is to evaluate the safety and effectiveness of infliximab (an anti-TNF chimeric monoclonal antibody [cA2]) in patients with active Rheumatoid Arthritis, despite methotrexate treatment.

本研究旨在评估英夫利昔单抗（infliximab，一种抗TNF嵌合单克隆抗体[cA2]）在尽管接受甲氨蝶呤治疗但仍处于活动期的类风湿关节炎（Rheumatoid Arthritis）患者中的安全性与有效性。